Form 8-K - Current report:
SEC Accession No. 0001214659-22-013717
Filing Date
2022-11-14
Accepted
2022-11-14 16:16:50
Documents
15
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 g11102228k.htm   iXBRL 8-K 29449
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 32191
7 GRAPHIC hgen_logo.jpg GRAPHIC 6614
  Complete submission text file 0001214659-22-013717.txt   290763

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hgen-20221114.xsd EX-101.SCH 3441
4 XBRL DEFINITION FILE hgen-20221114_def.xml EX-101.DEF 26174
5 XBRL LABEL FILE hgen-20221114_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE hgen-20221114_pre.xml EX-101.PRE 24832
9 EXTRACTED XBRL INSTANCE DOCUMENT g11102228k_htm.xml XML 4819
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 221385610
SIC: 2834 Pharmaceutical Preparations